Stock MNKD MANNKIND CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions MannKind Corporation

Equities

MNKD

US56400P7069

Market Closed - Nasdaq
Other stock markets
 16:00:01 2024-05-01 EDT 		5-day change 1st Jan Change
4.325 USD +5.23% Intraday chart for MannKind Corporation +3.22% +18.82%
04-30 MannKind Corporation to Proceed with Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases CI
04-29 MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. MNKD Stock
  4. Revisions MannKind Corporation